127 related articles for article (PubMed ID: 30393821)
1. Metabolomics Based on MS in Mice with Diet-Induced Obesity and Type 2 Diabetes Mellitus: the Effect of Vildagliptin, Metformin, and Their Combination.
Tomášová P; Bugáňová M; Pelantová H; Holubová M; Šedivá B; Železná B; Haluzík M; Maletínská L; Kuneš J; Kuzma M
Appl Biochem Biotechnol; 2019 May; 188(1):165-184. PubMed ID: 30393821
[TBL] [Abstract][Full Text] [Related]
2. Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.
Pelantová H; Bugáňová M; Holubová M; Šedivá B; Zemenová J; Sýkora D; Kaválková P; Haluzík M; Železná B; Maletínská L; Kuneš J; Kuzma M
Mol Cell Endocrinol; 2016 Aug; 431():88-100. PubMed ID: 27164444
[TBL] [Abstract][Full Text] [Related]
3. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans.
Nath S; Ghosh SK; Choudhury Y
J Pharmacol Toxicol Methods; 2017; 84():20-30. PubMed ID: 27773844
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
[TBL] [Abstract][Full Text] [Related]
5. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
Viriato D; Calado F; Gruenberger JB; Ong SH; Carvalho D; Silva-Nunes J; Johal S; Viana R
J Med Econ; 2014 Jul; 17(7):499-507. PubMed ID: 24708176
[TBL] [Abstract][Full Text] [Related]
7. The effects of high-fat diet and metformin on urinary metabolites in diabetes and prediabetes rat models.
Lee YF; Sim XY; Teh YH; Ismail MN; Greimel P; Murugaiyah V; Ibrahim B; Gam LH
Biotechnol Appl Biochem; 2021 Oct; 68(5):1014-1026. PubMed ID: 32931602
[TBL] [Abstract][Full Text] [Related]
8. A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM.
Matthews DR; Paldánius PM; Stumvoll M; Han J; Bader G; Chiang Y; Proot P; Del Prato S
Diabetes Obes Metab; 2019 Oct; 21(10):2240-2247. PubMed ID: 31144427
[TBL] [Abstract][Full Text] [Related]
9. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Metformin on Obesity-Induced Dysfunctional Retinas.
Kim AJ; Chang JY; Shi L; Chang RC; Ko ML; Ko GY
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):106-118. PubMed ID: 28114566
[TBL] [Abstract][Full Text] [Related]
12. The effects of liraglutide in mice with diet-induced obesity studied by metabolomics.
Bugáňová M; Pelantová H; Holubová M; Šedivá B; Maletínská L; Železná B; Kuneš J; Kačer P; Kuzma M; Haluzík M
J Endocrinol; 2017 Apr; 233(1):93-104. PubMed ID: 28138003
[TBL] [Abstract][Full Text] [Related]
13. Translating science into clinical practice: focus on vildagliptin in combination with metformin.
Barnett AH
Diabetes Obes Metab; 2009 May; 11 Suppl 2():18-26. PubMed ID: 19385980
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.
De Oliveira GL; Guerra Júnior AA; Godman B; Acurcio FA
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):109-119. PubMed ID: 28403729
[TBL] [Abstract][Full Text] [Related]
15. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
Göke R; Gruenberger JB; Bader G; Dworak M
Curr Med Res Opin; 2014 May; 30(5):785-9. PubMed ID: 24328429
[TBL] [Abstract][Full Text] [Related]
16. RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients.
Derosa G; Ragonesi PD; Carbone A; Fogari E; D'Angelo A; Cicero AF; Maffioli P
Pharmacol Res; 2013 Jul; 73():20-6. PubMed ID: 23624419
[TBL] [Abstract][Full Text] [Related]
17. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
Ahrén B; Foley JE; Bosi E
Diabetes Obes Metab; 2011 Mar; 13(3):193-203. PubMed ID: 21205107
[TBL] [Abstract][Full Text] [Related]
18. Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS).
Zhu Y; Feng Y; Shen L; Xu D; Wang B; Ruan K; Cong W
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():110-6. PubMed ID: 23523884
[TBL] [Abstract][Full Text] [Related]
19. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride.
Huo T; Cai S; Lu X; Sha Y; Yu M; Li F
J Pharm Biomed Anal; 2009 May; 49(4):976-82. PubMed ID: 19249171
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet.
Apaijai N; Pintana H; Chattipakorn SC; Chattipakorn N
Endocrinology; 2012 Aug; 153(8):3878-85. PubMed ID: 22621958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
